UBS Group’s iPath Series B S&P 500 VIX Short-Term Futures ETN VXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-63
Closed -$14.1K 10453
2022
Q4
$14.1K Buy
+63
New +$17.2K ﹤0.01% 8104
2020
Q2
Sell
-36
Closed -$106K 8403
2020
Q1
$106K Sell
36
-808
-96% -$1.31M ﹤0.01% 5248
2019
Q4
$816K Buy
+844
New +$1.02M ﹤0.01% 4398

Other funds holding VXX

UBS Group's VXX Position: Q2 2026 in Review

UBS Group increased its iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) stake by 796% in Q2 2026, buying an estimated $29.3M and bringing the position to 1,212,089 shares worth $26.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2387.

UBS Group first reported a position in VXX in Q1 2018 and has held it in 32 quarters since. 71 funds tracked by Wall St. Rank hold VXX as of Q2 2026.

  • UBS Group held 1,212,089 shares of iPath Series B S&P 500 VIX Short-Term Futures ETN worth $26.8M as of Q2 2026.
  • UBS Group bought 1,076,861 iPath Series B S&P 500 VIX Short-Term Futures ETN shares in Q2 2026, an estimated $29.3M.
  • iPath Series B S&P 500 VIX Short-Term Futures ETN made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2387 holding.
  • UBS Group first reported a position in iPath Series B S&P 500 VIX Short-Term Futures ETN in Q1 2018 and has held it in 32 quarters since.
  • 71 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Short-Term Futures ETN as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.